The development of ototoxicity in association with intravenous pamidro
nate treatment of Paget's disease is described. The patient developed
hearing loss, vertigo, and tinnitus which were exacerbated by subseque
nt infusions. This potentially serious drug side-effect does not appea
r to have been reported previously in patients with Paget's disease.